Endologix to Present at September Investment Conferences
September 08 2008 - 4:00AM
Business Wire
Endologix, Inc. (Nasdaq:ELGX) today announced that President and
Chief Executive Officer John McDermott will make presentations to
the investment community at the following investment conferences in
September. Next Generation Equity Research Small and Midcap
Investor Conference, a day of one-on-one meetings, on Tuesday,
September 9. This conference will be held at the Westin Times
Square Hotel in New York City. 2008 UBS Global Life Sciences
Conference on Tuesday, September 23 at 4:30 p.m. Eastern time. The
conference will be held at the Grand Hyatt Hotel in New York City.
Interested investors may gain access to a live audio webcast of the
UBS Global Life Sciences Conference presentation via the Internet
by visiting the Company�s Web site at www.endologix.com. Please go
to the Events & Presentations page on the Investor Relations
section of the Web site. The presentation will be available and
archived on the Web site for 30 days. About Endologix Endologix,
Inc. develops and manufactures minimally invasive treatments for
vascular diseases. Endologix's Powerlink System is an endoluminal
stent graft (ELG) for treating abdominal aortic aneurysms (AAA).
AAA is a weakening of the wall of the aorta, the largest artery in
the body, resulting in a balloon-like enlargement. Once AAA
develops, it continues to enlarge and, if left untreated, becomes
increasingly susceptible to rupture. The overall patient mortality
rate for ruptured AAA is approximately 75%, making it a leading
cause of death in the U.S. Additional information can be found on
Endologix�s Web site at www.endologix.com.
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From May 2024 to Jun 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jun 2023 to Jun 2024